Gerald Linette is a graduate of the Medical Scientist Training Program at Georgetown University School of Medicine. He completed training in internal medicine and molecular oncology at Washington University in St. Louis, followed by a fellowship in hematology-oncology at Massachusetts General Hospital/Dana-Farber Cancer Institute.
He is currently a professor of medicine and the medical director of the Parker Institute for Cancer Immunotherapy at the Perelman School of Medicine at the University of Pennsylvania. His primary interest is the development of cellular immunotherapies for melanoma and other solid tumors. His laboratory research is focused on human tumor neoantigen discovery.
Dr. Linette is board certified in internal medicine and medical oncology, and he maintains an active clinical practice at the Abramson Cancer Center at the University of Pennsylvania.
Education & Training
- 1980: St. Joseph's University , Philadelphia, PA, BS, Biology
- 1990: Georgetown University School of Medicine,Washington, D.C., PhD, Microbiology
- 1990: Georgetown University School of Medicine,Washington, D.C, MD
- 1991: Barnes Hospital, St. Louis, MO, Intern in Internal Medicine
- 1992: Barnes Hospital, St. Louis, MO, Resident in Internal Medicine
- 1995: Washington University, St. Louis, MO, Research Fellow in Molecular Oncology
- 1997: American Board of Internal Medicine, Internal Medicine, Certification
- 1998: Massachusetts General Hospital, Boston, MA, Fellow in Hematology-Oncology
- 2010: American Board of Internal Medicine, Medical Oncology, Certification